VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 90 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $485,465 | -96.2% | 31,647 | -94.1% | 0.00% | -100.0% |
| Q2 2023 | $12,668,079 | +211.2% | 532,496 | +232.8% | 0.00% | – |
| Q1 2023 | $4,071,061 | +131.1% | 160,026 | +165.4% | 0.00% | – |
| Q4 2022 | $1,761,480 | -8.9% | 60,304 | -36.0% | 0.00% | – |
| Q3 2022 | $1,934,000 | +40.3% | 94,286 | -20.8% | 0.00% | – |
| Q2 2022 | $1,378,000 | -45.4% | 119,054 | -12.7% | 0.00% | – |
| Q1 2022 | $2,522,000 | +130.1% | 136,427 | +146.3% | 0.00% | – |
| Q4 2021 | $1,096,000 | +287.3% | 55,400 | +222.1% | 0.00% | – |
| Q3 2021 | $283,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
| COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
| ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
| Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
| Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
| Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
| TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
| Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
| Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
| Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |